Cancer-Selective Targeting of the NF-kappa B Survival Pathway with GADD45 beta/MKK7 Inhibitors

Research output: Contribution to journalArticle (Academic Journal)peer-review

93 Citations (Scopus)
Original languageUndefined/Unknown
JournalCancer Cell
DOIs
Publication statusPublished - Oct 2014

Cite this